Removing Lipemia in Serum/Plasma Samples: A Multicenter Study
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Lipemia, a significant source of analytical errors in clinical laboratory settings, should be removed prior to measuring biochemical parameters. We investigated whether lipemia in serum/plasma samples can be removed using a method that is easier and more practicable than ultracentrifugation, the current reference method. Methods: Seven hospital laboratories in Spain participated in this study. We first compared the effectiveness of ultracentrifugation (108,200×g) and high-speed centrifugation (10,000×g for 15 minutes) in removing lipemia. Second, we compared high-speed centrifugation with two liquid-liquid extraction methods—LipoClear (StatSpin, Norwood, USA), and 1,1,2-trichlorotrifluoroethane (Merck, Darmstadt, Germany). We assessed 14 biochemical parameters: serum/plasma concentrations of sodium ion, potassium ion, chloride ion, glucose, total protein, albumin, creatinine, urea, alkaline phosphatase, gamma-glutamyl transferase, alanine aminotransferase, aspartate-aminotransferase, calcium, and bilirubin. We analyzed whether the differences between lipemia removal methods exceeded the limit for clinically significant interference (LCSI). Results: When ultracentrifugation and high-speed centrifugation were compared, no parameter had a difference that exceeded the LCSI. When high-speed centrifugation was compared with the two liquid-liquid extraction methods, we found differences exceeding the LCSI in protein, calcium, and aspartate aminotransferase in the comparison with 1,1,2-trichlorotrifluoroethane, and in protein, albumin, and calcium in the comparison with LipoClear. Differences in other parameters did not exceed the LCSI. Conclusions: High-speed centrifugation (10,000×g for 15 minutes) can be used instead of ultracentrifugation to remove lipemia in serum/plasma samples. LipoClear and 1,1,2-trichlorotrifluoroethane are unsuitable as they interfere with the measurement of certain parameters.
Abstract
Background: Lipemia, a significant source of analytical errors in clinical laboratory settings, should be removed prior to measuring biochemical parameters. We investigated whether lipemia in serum/plasma samples can be removed using a method that is easier and more practicable than ultracentrifugation, the current reference method. Methods: Seven hospital laboratories in Spain participated in this study. We first compared the effectiveness of ultracentrifugation (108,200×g) and high-speed centrifugation (10,000×g for 15 minutes) in removing lipemia. Second, we compared high-speed centrifugation with two liquid-liquid extraction methods—LipoClear (StatSpin, Norwood, USA), and 1,1,2-trichlorotrifluoroethane (Merck, Darmstadt, Germany). We assessed 14 biochemical parameters: serum/plasma concentrations of sodium ion, potassium ion, chloride ion, glucose, total protein, albumin, creatinine, urea, alkaline phosphatase, gamma-glutamyl transferase, alanine aminotransferase, aspartate-aminotransferase, calcium, and bilirubin. We analyzed whether the differences between lipemia removal methods exceeded the limit for clinically significant interference (LCSI). Results: When ultracentrifugation and high-speed centrifugation were compared, no parameter had a difference that exceeded the LCSI. When high-speed centrifugation was compared with the two liquid-liquid extraction methods, we found differences exceeding the LCSI in protein, calcium, and aspartate aminotransferase in the comparison with 1,1,2-trichlorotrifluoroethane, and in protein, albumin, and calcium in the comparison with LipoClear. Differences in other parameters did not exceed the LCSI. Conclusions: High-speed centrifugation (10,000×g for 15 minutes) can be used instead of ultracentrifugation to remove lipemia in serum/plasma samples. LipoClear and 1,1,2-trichlorotrifluoroethane are unsuitable as they interfere with the measurement of certain parameters.
참고문헌 (18)
- Kroll M, "Evaluating interference caused by lipaemia", Clin Chem, 50, pp.1968~1969 (2004)
- Farrell CL, "Serum indices : managing assay interference", Ann Clin Biochem, 53, pp.527~538 (2016)
- Ryder KW, "Incidence and amount of turbidity, hemolysis, and icterus in serum from outpatients", Lab Med, 22, pp.415~418 (1991)
- Nikolac N, "Lipaemia: causes, interference mechanisms, detection and management", Biochem Med, 24, pp.57~67 (2014)
- Goldenberg NM, "An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia", Clin Chim Acta, 332, pp.11~19 (2003)
- Calmarza P, "Lipaemia interferences in routine clinical biochemical tests", Biochem Med, 21, pp.160~166 (2011)
- Walker PL, "Lipaemia: causes, consequences and solutions", Clin Chim Acta, 418, pp.30~32 (2013)
- Dimeski G, "Interference testing", Clin Biochem Rev, 29(S1), pp.S43~S48 (2008)
- Dimeski G, "Lipaemic samples: effective process for lipid reduction using high speed centrifugation compared with ultracentrifugation", Biochem Med, 21, pp.86~92 (2011)
- CLSI, "Hemolysis, icterus, and lipaemia", turbidity indices as indicators of interference in clinical laboratory analysis. CLSI C56, 2011
- Vermeer HJ, "Correction of patient results for Beckman Coulter LX-20 assays affected by interference due to hemoglobin, bilirubin or lipids : a practical approach", Clin Chem Lab Med, 45, pp.114~119 (2007)
- Saracevic A, "The evaluation and comparison of consecutive high speed centrifugation and LipoClear® reagent for lipaemia removal", Clin Biochem, 47, pp.309~314 (2014)
- Bergmeyer HU, "Approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase", J Clin Chem Clin Biochem, 24, pp.481~495 (1986)
- Bergmeyer HU, "Approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 2. IFCC Method for aspartate aminotransferase", J Clin Chem Clin Biochem, 24, pp.497~510 (1986)
- Tietz NW, "International Federation of Clinical Chemistry. IFCC methods for the measurement of catalytic concentration of enzymes, Part 5. IFCC method for alkaline phosphatase (orthophosphoric-monoester phosphohydrolase, alkaline optimum, EC 3.1.3.1)", J Clin Chem Clin Biochem, 21, pp.731~748 (1983)
- Szasz G, "New substrates for measuring gamma-glutamyl-transpeptidase activity", Z Klin Chem Klin Biochem, 12, pp.228~ (1974)
- Spanish Society of Clinical Biochemistry, "Criteria for the assessment of the analytical and clinical significance of interferences in clinical biochemistry", Quim Clínica, 14, pp.107~109 (1995)
- CLSI, "Statistical quality control for quantitative measurement procedures: principles and definitions; approved guideline. CLSI C24-A3", Clinical Laboratory Standards Institute, ~ (2006)